Exchange Announcement • 30 Oct 2024 14:46
Exchange Announcement • 30 Oct 2024 14:27
Exchange Announcement • 09 Sep 2024 15:00
Exchange Announcement • 29 Aug 2024 09:48
Exchange Announcement • 28 Aug 2024 13:30
ENTITY
SK Biopharmaceuticals (326030 KS)
SK Biopharmaceuticals (326030 KS)
128
Analysis
Health Care • South Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
x